Gabapentin Drug Classification
Gabapentin belongs to the calcium channel α2δ ligands drug class.
Pharmacological Classification
Gabapentin is formally classified as a calcium channel α2δ ligand (also called gabapentinoid), which represents its primary mechanism of action 1. This classification is based on its binding to the α2δ subunit of voltage-gated calcium channels, which inhibits neurotransmitter release 1.
Key Classification Details:
- Primary class: Calcium channel α2δ ligands 1
- Structural relationship: While gabapentin is structurally related to the neurotransmitter GABA (gamma-aminobutyric acid), it has no effect on GABA binding, uptake, or degradation 2
- Not a GABA mimetic: Despite its structural similarity to GABA, gabapentin does not function as a GABA analog in terms of mechanism 2
Mechanism of Action
The FDA label confirms that gabapentin binds with high affinity to the α2δ subunit of voltage-activated calcium channels, though the precise relationship of this binding to therapeutic effects remains incompletely understood 2. This binding modulates calcium channel activity and neurotransmitter release, particularly glutamate release at presynaptic terminals 3.
Important Caveats:
- Gabapentin is not classified as an anticonvulsant or antiepileptic in terms of drug class, though it is used for epilepsy treatment
- It is not a controlled substance and is not scheduled 2
- Pregabalin, which shares the same drug class (calcium channel α2δ ligands), is a Schedule V controlled substance in the United States 1
The term "gabapentinoid" is increasingly used in clinical practice to refer to this drug class, which includes both gabapentin and pregabalin 4, 5.